HK Stock Market Move | EXTRAWELL PHAR(00858) surged over 45% after Yixin's rise, with expected mid-term profit of around HK$105 million and turning loss into profit year-on-year.
Sino Biopharmaceutical (00858) rose more than 45% after announcing its profit. As of the time of writing, it rose by 45.83%, reaching HKD 0.07, with a turnover of HKD 972,700.
EXTRAWELL PHAR (00858) rose over 45% after profit announcement, reaching 0.07 Hong Kong dollars, with a total turnover of 972,700 Hong Kong dollars as of the time of publication.
On the news front, EXTRAWELL PHAR announced that the group expects to achieve a profit of approximately 100 million Hong Kong dollars to 105 million Hong Kong dollars for the six-month period ending September 30, 2024, compared to a loss for the same period ending September 30, 2023. The expected turnaround from loss to profit in this period is mainly due to non-cash items, resulting from the gain on fair value changes in financial assets recognized in the income statement, while a loss was incurred in the same period in 2023 for the same non-cash item.
Related Articles

Open Source Securities: Changes to this round of spring excitement after 8 consecutive gains

Huajin Securities: The spring market in January next year may continue, and technology is leading in some cyclical industries such as CKH HOLDINGS.

New stock prospects | 90% of revenue comes from the United States, how long can Universal Horticulture continue to benefit from going global?
Open Source Securities: Changes to this round of spring excitement after 8 consecutive gains

Huajin Securities: The spring market in January next year may continue, and technology is leading in some cyclical industries such as CKH HOLDINGS.

New stock prospects | 90% of revenue comes from the United States, how long can Universal Horticulture continue to benefit from going global?

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


